Bristol-Myers Squibb Company PFD CONV 2 BMYMP
400.00 USD 0.00 (+0.00%)
Mar 18, 2026, 2:07 PM EDT
400.00 52-week range 1,050.00
- YTD
- -55.56%
- 1 year
- -61.87%
Altman Z-Score
-5.63 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 15.6×
P/S 2.3×
P/B 6.0×
P/FCF 8.6×
EV/EBITDA 9.7×
EV/Sales 3.1×
FCF Yield 11.7%
Gross Margin 71.1%
Operating Margin 28.5%
Net Margin 14.6%
ROE 38.2%
ROIC 15.0%
ROA 7.8%
Revenue -0.2%
Operating Income 133.1%
EPS (diluted) 178.2%
Free Cash Flow -7.9%
Current Ratio 1.3×
Quick Ratio 1.1×
Debt / Equity 2.6×
Net Debt / EBITDA 2.4×
Interest Coverage 7.3×
Dividend Yield 4.6%
Payout Ratio 71.5%
Annual · latest fiscal year ends 2025-12-31